The Governing Board was established by the Council’s funders in 2017. It is responsible for reviewing and challenging the work of the Council, providing assurance that the Council is operating within its remit and is committing expenditure in line with the terms of the funding grant and the goals of the Strategic Plan. Specifically, the Governing Board approves topic selections, budget and annual work plans, and oversees risk management and financial operations. The Governing Board meets twice a year with the Council’s Chair and Director in attendance.
The Chair of the Governing Board and its other members are independent and appointed and remunerated by the funders.
Members of the Governing Board
Brian Scott (Chair)
Since finishing as chief executive of Oxfam Ireland, Brian Scott has concentrated on serving on a range of non-profit boards in overseas related education and health activities, and is Chairperson at the Meningitis Research Foundation. He has also served for seven years as non-executive director of one of Northern Ireland government departments involved in further and high education and vocational training.
Stephen Holgate is Medical Research Council Clinical Professor of Immunopharmacology and Honorary Consultant Physician within Medicine at the University of Southampton. He chairs, or is a member of, a number of committees and boards, including chairing the UK National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), the Kennedy Trust for rheumatology Research and the Natural Environment Research Council. He is also a member of the Trustee Board for Great Ormond Hospital Children’s Charity, Trustee of Cancer Research UK and cofounder of Synairgen, a publically quoted respiratory drug development company.
Vivienne Parry is a science journalist and author, who hosts medical programmes for Radio 4, writes widely on health, presents films, and facilitates high level conferences and debates. She is currently employed as Head of Engagement at Genomics England and is on the board of UK Research & Innovation.
Chaired by an external chair, the Membership Committee considers and makes recommendations to the Council on future membership.
Sarah Guerra, Chair
Sarah Guerra is the Director of King's College London’s Equality, Diversity & Inclusion. She spearheads their strategic vision for diversity, equality and inclusion for the whole campus community.
She has instigated a suite of strategic projects to revolutionise attitudes towards equality, diversity and inclusion, championed the use of data to build an evidence base for all activity and is supporting King’s in realising its 'inclusion journey'.
In addition to her work at King's, she sits on the Research Excellence Framework's Equality and Diversity Advisory Panel as well as the AdvanceHE's Equality, Diversity and Inclusion Committee.
A born and bred black Londoner and mother of four daughters in a blended family, Sarah has worked in Diversity & Inclusion in several organisations in other sectors including being a Non-Executive Director of the Civil Service Race Forum.
Professor Dave Archard
Chair of the Council, Emeritus Professor of Philosophy at Queen’s University Belfast.
Member of the Nuffield Council on Bioethics and Emeritus Professor of Clinical Genetics at Guy’s & St Thomas NHS Foundation Trust.
Member of the Nuffield Council on Beiothics and former Consultant Psychiatrist, with extensive experience in national and international bioethics policy.
Member of the Nuffield Council on Bioethics and Professor of Sociology and Head of the School of Social and Political Sciences at the University of Glasgow.
Member of the Council’s Governing Board, Chairperson at Meningitis Research Foundation.
Other Council Members are co-opted onto the subgroup depending on the expertise required for each particular meeting.
Strategic Plan 2018-2022
The Council published its current Strategic Plan in April 2018.
The plan sets out four strategic goals for the period 2018-2022, and the programmes of work through which these will be delivered.
Our strategic goals are:
- We will engage and involve relevant stakeholders in our work.
- We will contribute effectively to public and policy debates through a diverse portfolio of work.
- We will build on our experience, reputation and body of work.
- We will situate our work within a context of social change, international collaboration, and biomedical advances.
- Annual report 2020
- Annual Report 2019
- Annual Report 2018
- Annual Report 2017
- Annual Report 2016
- Annual Report 2015
- Annual Report 2014
- Annual Report 2013
- Annual Report 2012
- Anniversary review 1991 – 2011
- Annual Report 2011
- Annual Report 2010
- Annual Report 2009
- Annual Report 2008
- Annual Report 2007
- Annual Report 2006
- Annual Report 2005
- Annual Report 2004
- Annual Report 2003
- Annual Report 2002
- Annual Report 2001
- Annual Report 2000
- Review 1992-1999